Samantha McLemore - Patient Capital Management,
Holding/activity history for Karuna Therapeutics Inc (KRTX)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2024 Q1 | 0 | 0.00 | Sell 100.00% | 0.20 | SEC | ||
| 2023 Q4 | 11,631 | 0.20 | Reduce 93.40% | 1.64 | $316.50 | $3,681,219 | SEC |
| 2023 Q3 | 176,252 | 1.76 | Reduce 0.32% | <0.01 | $169.09 | $29,802,411 | SEC |
| 2023 Q2 | 176,826 | 2.14 | Add 656.47% | 1.86 | $216.85 | $38,344,818 | SEC |
| 2023 Q1 | 23,375 | 1.90 | Add 32.06% | 0.46 | $181.64 | $4,245,835 | SEC |
| 2022 Q4 | 17,700 | 1.72 | $196.50 | $3,478,050 | SEC | ||
| 2022 Q3 | 17,700 | 2.02 | Reduce 8.29% | 0.10 | $224.92 | $3,981,000 | SEC |
| 2022 Q2 | 19,300 | 1.20 | Add 8.43% | 0.09 | $126.53 | $2,442,000 | SEC |
| 2022 Q1 | 17,800 | 0.89 | Reduce 7.29% | 0.07 | $126.80 | $2,257,000 | SEC |
| 2021 Q4 | 19,200 | 1.02 | $130.99 | $2,515,000 | SEC |